Article History
Accepted: 19 July 2021
First Online: 25 August 2021
Declarations
:
: EML: Apellis, LumiThera, Novartis, and Roche (through Duke University).
: VF: none; MGC: none; EML: Consultant—Apellis, Galimedix, Genentech/Roche, Novartis, Retrotope, Gemini Therapeutics, Allegro, and Alexion.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.